←
Faraidoon Haghdoost (Big Head Pain)4,457 posts
Faraidoon Haghdoost (Big Head Pain) avatar

Faraidoon Haghdoost (Big Head Pain)

@faradoost

MD, PhD, Research Fellow in Headache disorders, @georgeinstitute, conjoint senior lecturer @unsw, Australia. Social Media Editor @JCephalalgia, #BigHeadPain

◷ Joined August 2016▧ 666 Photos and videos
Faraidoon Haghdoost (Big Head Pain) avatar
Faraidoon Haghdoost (Big Head Pain)@faradoost·Nov 10

~4 million Australians live with migraine. Yet our new paper found just ONE NHMRC/MRFF-funded headache clinical trial from 2013–2025, and NONE for migraine or tension-type headache. We need stronger investment and research capacity.

New in Cephalalgia Reports! Headache disorders are a leading cause of disability, yet publicly funded headache clinical trials in Australia are remarkably scarce. This new paper highlights the gap and the opportunity for change. Article highlights • No funded clinical trials were identified for migraine or tension-type headache, despite their substantial burden. • A review of NHMRC and MRFF funding in Australia identified only one funded headache disorder clinical trial since 2013, focused on cluster headache. • Increased investment in headache clinical trials, workforce development, and national research infrastructure could help accelerate evidence generation and improve patient outcomes. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience @faradoost

Post attachment
Cephalalgia avatar
⟳ Faraidoon Haghdoost (Big Head Pain) retweeted
Cephalalgia@JCephalalgia·Nov 10

New in Cephalalgia Reports! Headache disorders are a leading cause of disability, yet publicly funded headache clinical trials in Australia are remarkably scarce. This new paper highlights the gap and the opportunity for change. Article highlights • No funded clinical trials were identified for migraine or tension-type headache, despite their substantial burden. • A review of NHMRC and MRFF funding in Australia identified only one funded headache disorder clinical trial since 2013, focused on cluster headache. • Increased investment in headache clinical trials, workforce development, and national research infrastructure could help accelerate evidence generation and improve patient outcomes. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience @faradoost

Post attachment
Cephalalgia avatar
⟳ Faraidoon Haghdoost (Big Head Pain) retweeted
Cephalalgia@JCephalalgia·Nov 5

Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society. 🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions. We welcome: • Original research and clinical trials • Systematic reviews and network meta-analyses • Real-world evidence • Viewpoints and perspectives If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you. 📅 Submission deadline: 31 December 2026 📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue. Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together. surl.lt/wadtdt #migraine #headache #brain #pain #neurology #neuroscience @faradoost @Simona_Sacco_ @HenrikSchytz

Post attachment
International Headache Society avatar
⟳ Faraidoon Haghdoost (Big Head Pain) retweeted
International Headache Society@ihs_official·Nov 5

Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society. 🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions. We welcome: • Original research and clinical trials • Systematic reviews and network meta-analyses • Real-world evidence • Viewpoints and perspectives If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you. 📅 Submission deadline: 31 December 2026 📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue. Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together. surl.lt/wadtdt #migraine #headache #brain #pain #neurology #neuroscience @faradoost @Simona_Sacco_ @HenrikSchytz

Post attachment
Shadi Yaghi avatar
⟳ Faraidoon Haghdoost (Big Head Pain) retweeted
Shadi Yaghi@ShadiYaghi2·Nov 1

A breakthrough in stroke care 🧠 Jersey Shore University Medical Center is using cutting-edge MRI technology to help identify patients who may benefit from life-saving treatment even when they wake up with stroke symptoms & don’t know when it started. patch.com/new-jersey/asbury-…

Hypertension avatar
⟳ Faraidoon Haghdoost (Big Head Pain) retweeted
Hypertension@HyperAHA·Oct 19

RESEARCH ARTICLE: Association Between Follow-Up Mean Blood Pressure and Blood Pressure Control: A Meta-Regression Analysis of 101 Randomized Trials @faradoost ahajrnls.org/4k5K2nD

Post attachment
ひふみ|頭痛と脳神経外科 avatar
⟳ Faraidoon Haghdoost (Big Head Pain) retweeted
ひふみ|頭痛と脳神経外科@dr_hifumi·Oct 15

CGRPは血管拡張作用があります💉 よって片頭痛予防の抗CGRP薬は、 「血圧が上がるのでは?」🤷 と懸念されていました。 約1.9万人を対象としたメタアナリシス →抗CGRPでの明らかな血圧上昇は見られなかったそうです。 少なくとも短期的には、大きな影響はなさそうですね🤔

New in Cephalalgia Reports! Meta-analysis of FDA trial data shows anti-CGRP therapies are not associated with clinically significant increases in blood pressure, supporting their cardiovascular safety in migraine treatment. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience @faradoost

Post attachment
Faraidoon Haghdoost (Big Head Pain) avatar
Faraidoon Haghdoost (Big Head Pain)@faradoost·Oct 14

Do anti-CGRP migraine medications increase blood pressure? We analysed FDA data from 20 RCTs and 18,886 participants. Reassuringly, neither anti-CGRP monoclonal antibodies nor gepants were associated with significant increases in BP vs placebo.

Post attachment

New in Cephalalgia Reports! Meta-analysis of FDA trial data shows anti-CGRP therapies are not associated with clinically significant increases in blood pressure, supporting their cardiovascular safety in migraine treatment. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience @faradoost

Post attachment